COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry

Jerin Jose*, Elif Seda Selamet Tierney, Ashraf S. Harahsheh, Nagib Dahdah, Geetha Raghuveer, Kevin G. Friedman, Michael Khoury, Mark D. Hicar, Shae A. Merves, Frederic Dallaire, Pedrom Farid, Cedric Manlhiot, Kyle Runeckles, Nilanjana Misra, Michael Portman, Jean A. Ballweg, Simon Lee, Supriya S. Jain, Tyler H. Harris, Jacqueline R. SzmuszkoviczWilliam Orr, Guillermo Larios, Brian W. McCrindle

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


To determine clinical differences for children with complete Kawasaki disease (KD) with and without evidence of preceding SARS-CoV-2 infection. From January 2020, contemporaneous patients with complete KD criteria were classified as either SARS-CoV-2 positive (KDCOVID+; confirmed household exposure, positive PCR and/or serology) or SARS-CoV-2 negative (KDCOVID−; negative testing and no exposure) and compared. Of 744 patients in the International Kawasaki Disease Registry, 52 were KDCOVID− and 61 were KDCOVID+. KDCOVID+ patients were older (median 5.5 vs. 3.7 years; p < 0.001), and all additionally met diagnostic criteria for multisystem inflammatory syndrome in children (MIS-C). They were more likely to have abdominal pain (60% vs. 35%; p = 0.008) and headache (38% vs. 10%; p < 0.001) and had significantly higher CRP, troponin, and BUN/creatinine, and lower hemoglobin, platelets, and lymphocytes. KDCOVID+ patients were more likely to have shock (41% vs. 6%; p < 0.001), ICU admission (62% vs. 10%; p < 0.001), lower left ventricular ejection fraction (mean lowest LVEF 53% vs. 60%; p < 0.001), and to have received inotropic support (60% vs. 10%; p < 0.001). Both groups received IVIG (2 doses in 22% vs. 18%; p = 0.63), but KDCOVID+ were more likely to have received steroids (85% vs. 35%; p < 0.001) and anakinra (60% vs. 10%; p = 0.002). KDCOVID− patients were more likely to have medium/large coronary artery aneurysms (CAA, 12% vs. 0%; p = 0.01). KDCOVID+ patients differ from KDCOVID−, have more severe disease, and greater evidence of myocardial involvement and cardiovascular dysfunction rather than CAA. These patients may be a distinct KD phenotype in the presence of a prevalent specific trigger.

Original languageEnglish (US)
Pages (from-to)1373-1381
Number of pages9
JournalPediatric cardiology
Issue number6
StatePublished - Aug 2023


  • COVID-19
  • Kawasaki
  • MIS-C
  • MIS-C with KD phenotype
  • SARS-CoV-2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry'. Together they form a unique fingerprint.

Cite this